TCT-38 Ticagrelor With and Without Aspirin in Patients With Previous Coronary Artery Bypass Graft Undergoing Percutaneous Coronary Intervention: The TWILIGHT-CABG Subanalysis
Frans Beerkens(Icahn School of Medicine at Mount Sinai), Roxana Mehran(Mount Sinai Hospital), Samantha Sartori(Icahn School of Medicine at Mount Sinai), Carlo Andrea Pivato(Cardiovascular Institute of the South), Samin K. Sharma(Mount Sinai Health System), Dominick J. Angiolillo(University of Florida), David Power(Cardiovascular Institute of the South), Davis Jones(Cardiovascular Institute of the South), George Dangas(Mount Sinai Hospital), Shamir R. Mehta(Population Health Research Institute), Timothy Collier(London School of Hygiene & Tropical Medicine), Victor Razuk(Mount Sinai Hospital), Richard Shlofmitz(St. Francis Hospital), Anton Camaj(Columbia University Irving Medical Center), Zhongjie Zhang(Shanxi Medical University), Johny Nicolas(Cardiovascular Institute of the South), Gennaro Sardella(Policlinico Umberto I), Stuart Pocock(London School of Hygiene & Tropical Medicine), Davide Cao(Cardiovascular Institute of the South), C. Michael Gibson(Baim Institute for Clinical Research), Bimmer E. Claessen(Columbia University Irving Medical Center)
Cited by 0
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
|New England Journal of Medicine|2016|1.5k